Oxytocin and Facial Recognition: How the Love Hormone Helps Us Read Faces

Every social interaction begins with a face. Within milliseconds, your brain decodes a constellation of micro-expressions – a furrowed brow, a tightened jaw, the crinkle around someone’s eyes – to infer what another person is feeling. This ability, known as facial emotion recognition, is one of the most fundamental skills in human social life. And increasingly, neuroscience research points to a single neuropeptide as a key regulator of how well we perform it: oxytocin.

Oxytocin – often called the “love hormone” – is a nine-amino-acid peptide produced in the hypothalamus and released into the brain and bloodstream. While it is best known for its roles in childbirth and bonding, a growing body of evidence shows that oxytocin fundamentally shapes how we perceive and interpret faces. From enhancing our ability to read subtle emotional cues to directing our gaze toward the eyes, oxytocin and facial recognition are deeply intertwined.

This page reviews the key scientific evidence on oxytocin’s role in face reading, emotion recognition, eye contact, and broader social cognition – including implications for autism spectrum conditions and trust.

Reading the Mind in the Eyes: Oxytocin and Emotion Recognition

The landmark study that brought oxytocin and emotion recognition into mainstream neuroscience was conducted by Gregor Domes and colleagues in 2007. Published in Biological Psychiatry, the study used Baron-Cohen’s “Reading the Mind in the Eyes” Test (RMET) – a well-validated measure of emotional and mental state attribution from photographs of the eye region alone.

In this double-blind, placebo-controlled crossover design, 30 healthy male participants received either 24 IU of intranasal oxytocin or placebo before completing the RMET. The results were striking: oxytocin significantly improved the ability to infer complex mental states from the eye region of faces. Crucially, this effect was most pronounced for items rated as “difficult” – those requiring fine-grained discrimination between subtly different emotional states (Domes et al., 2007, Biological Psychiatry, 61(6), 731–733).

This finding was pivotal. The RMET is not a simple emotion-labelling task; it requires understanding nuanced psychological states such as “contemplative,” “suspicious,” or “playful.” Oxytocin, it appeared, was not merely sharpening basic perceptual processes but enhancing a higher-order capacity often called affective theory of mind – the ability to attribute emotional states to others based on limited visual cues.

Subsequent replications and extensions have confirmed this core finding. A 2010 study by Lischke and colleagues demonstrated that oxytocin improved the recognition of facial expressions even at lower intensities – meaning participants could correctly identify emotions that were morphed to be more ambiguous or subtle (Psychoneuroendocrinology, 35(1), 83–93). This suggests that oxytocin lowers the threshold at which emotional signals in faces become readable.

Oxytocin and Eye Contact: Where You Look Matters

If oxytocin helps us read emotions from faces, one key mechanism appears to be where it directs our gaze. In 2008, Adam Guastella and colleagues published a now-classic eye-tracking study in Biological Psychiatry showing that intranasal oxytocin increased the amount of time participants spent fixating on the eye region of faces.

This is significant because the eyes are the most informationally dense region of the face for social and emotional communication. The eye region conveys fear, surprise, contempt, and affection in ways that the mouth and lower face cannot. When we say someone has “kind eyes” or “cold eyes,” we are responding to subtle configurations of the orbicularis oculi, corrugator, and levator muscles – all concentrated around the eyes.

Guastella et al. (2008) used a free-viewing paradigm in which participants looked at photographs of faces while their eye movements were tracked. Those who received 24 IU of intranasal oxytocin (versus placebo) showed significantly increased gaze time to the eye region across all face types – happy, angry, and neutral. The effect was not limited to threatening or rewarding faces; it was a broad attentional shift toward the most socially informative part of the face (Biological Psychiatry, 63(1), 3–5).

This gaze-direction mechanism helps explain why oxytocin improves facial recognition and emotion reading. By increasing attention to the eyes, oxytocin ensures that the brain receives richer social signal input, which in turn supports more accurate emotion decoding. It is a simple but elegant mechanism: look at the right place, and you read the emotion better.

A follow-up study by Gamer, Zurowski, and Büchel (2010), published in the Journal of Neuroscience, combined eye-tracking with functional MRI to show that oxytocin simultaneously increased gaze to the eye region and enhanced functional connectivity between the amygdala and the superior colliculus – a midbrain structure involved in directing eye movements. This finding suggested that oxytocin’s gaze-shifting effects are not merely behavioural but reflect a reorganisation of subcortical circuits that orient social attention (30(26), 8692–8698).

Amygdala Modulation: How Oxytocin Changes Fear Face Processing

The amygdala is the brain’s sentinel for threat. It responds rapidly to fearful faces, angry expressions, and ambiguous social stimuli. But the amygdala’s response to faces is not fixed – it is modulated by oxytocin in ways that have profound implications for social cognition and emotional regulation.

The foundational neuroimaging study on this topic was conducted by Peter Kirsch and colleagues in 2005, published in the Journal of Neuroscience. Using fMRI, they demonstrated that intranasal oxytocin significantly reduced amygdala activation in response to threatening social stimuli – specifically fearful and angry faces. Oxytocin also reduced functional coupling between the amygdala and brainstem regions associated with autonomic fear responses (25(49), 11489–11493).

This amygdala-dampening effect has been replicated across multiple laboratories and paradigms. Domes et al. (2007b) showed reduced amygdala reactivity to fearful faces following oxytocin administration, while Petrovic and colleagues (2008) demonstrated similar effects using conditioned fear stimuli (Social Cognitive and Affective Neuroscience, 3(1), 37–43).

The implication is that oxytocin does not simply enhance positive social perception – it actively reduces the neural alarm response to potentially threatening faces. This dual action – amplifying attention to social cues while dampening threat reactivity – creates a neurochemical environment that favours approach over avoidance, trust over suspicion.

However, this picture is nuanced. More recent research has shown that oxytocin’s effects on the amygdala are context-dependent. Shamay-Tsoory and Abu-Akel (2016) proposed an influential “social salience” model suggesting that oxytocin amplifies the salience of social cues generally – not just positive ones. In competitive or threatening social contexts, oxytocin can actually increase amygdala reactivity and defensive behaviours (Trends in Cognitive Sciences, 20(5), 375–386).

Oxytocin and Trustworthiness Judgments from Faces

We make snap judgments about whether someone is trustworthy within 100 milliseconds of seeing their face – and these judgments, however unreliable, influence real-world decisions from voting behaviour to criminal sentencing. Oxytocin modulates this process at multiple levels.

Theodoridou and colleagues (2009) demonstrated that intranasal oxytocin made participants rate unfamiliar faces as more trustworthy and more attractive. This was not a general positive-affect shift; oxytocin specifically altered evaluative judgments about faces in a pro-social direction (Biological Psychology, 82(1), 57–61).

Kosfeld et al. (2005), in a landmark study published in Nature, showed that oxytocin increased trusting behaviour in economic games – participants who received oxytocin transferred significantly more money to anonymous partners, suggesting greater willingness to accept social risk. While this study did not specifically measure face-based judgments, subsequent work has connected oxytocin’s trust-enhancing effects to altered processing of facial cues (435(7042), 673–676).

The connection between oxytocin, face reading, and trust is likely mediated by the amygdala effects described above. When the amygdala’s threat response to faces is dampened, the same face that might have triggered wariness instead triggers approach – and the conscious experience of this shift is registered as “this person seems trustworthy.” Learn more about oxytocin and trust.

Facial Recognition in Autism: Oxytocin as a Potential Therapeutic

Autism spectrum conditions (ASC) are characterised, among other features, by difficulties with face processing, emotion recognition, and eye contact. Given oxytocin’s demonstrated effects in all three domains, it became a natural candidate for therapeutic investigation in autism.

Early results were promising. Guastella and colleagues (2010) conducted the first randomised controlled trial of intranasal oxytocin for social cognition in young people with autism. Published in Biological Psychiatry, the study found that a single dose of oxytocin improved performance on the RMET in adolescents aged 12–19 with autism spectrum conditions (67(7), 692–694).

Andari and colleagues (2010) extended these findings by showing that oxytocin increased both social attention (measured by eye-tracking during a ball-tossing game) and the ability to discriminate between cooperative and non-cooperative partners in adults with high-functioning autism. Importantly, oxytocin specifically enhanced attention to faces and the eye region during social interactions (Proceedings of the National Academy of Sciences, 107(9), 4389–4394).

Domes et al. (2013) further demonstrated that oxytocin improved emotion recognition from faces in adults with Asperger syndrome, with particular improvement for “difficult” items on the RMET – mirroring the pattern seen in neurotypical individuals (Translational Psychiatry, 3(1), e220).

However, larger and longer-term trials have produced more mixed results. A 2021 systematic review by Sikich et al. in the New England Journal of Medicine found that daily intranasal oxytocin over 24 weeks did not significantly improve social functioning in children and adolescents with autism compared to placebo (385(16), 1462–1473). This landmark negative result suggests that while acute doses may enhance specific cognitive tasks in laboratory settings, translating these effects into sustained real-world social improvements remains challenging.

The current consensus is cautious: oxytocin may modulate specific face-processing and emotion recognition mechanisms in autism, but it is unlikely to be a standalone treatment. Its future may lie in combination with behavioural therapies – enhancing the brain’s receptivity to social learning during structured interventions. For a comprehensive overview, see our page on oxytocin and autism.

Neural Mechanisms: How Oxytocin Shapes Face Processing in the Brain

Face processing in the brain involves a distributed network centred on the fusiform face area (FFA), the superior temporal sulcus (STS), and the amygdala. Each region contributes differently: the FFA handles face identity and structural encoding, the STS processes changeable aspects like expression and gaze direction, and the amygdala evaluates the emotional significance of faces.

Oxytocin appears to modulate all three nodes of this network, though its effects on the amygdala are best established. Riem and colleagues (2011) showed that oxytocin increased amygdala responses to infant faces – particularly crying infants – in new mothers, suggesting that oxytocin sensitises the amygdala to caregiving-relevant face stimuli (NeuroImage, 56(3), 1399–1405). This finding reframes the amygdala story: rather than simply dampening threat responses, oxytocin may be tuning the amygdala’s responsiveness to match social context and biological relevance.

At the computational level, Woolley and colleagues (2014) proposed that oxytocin increases the signal-to-noise ratio in social perception – enhancing the precision of predictions about others’ mental states while reducing the influence of prior negative expectations (Psychopharmacology, 231(6), 1137–1144). This predictive-coding framework offers an elegant integration of oxytocin’s diverse effects on face processing, gaze direction, and emotion reading.

Oxytocin and Social Cognition: The Broader Picture

Oxytocin and social cognition extend well beyond face reading. Oxytocin influences memory for faces (Rimmele et al., 2009, Journal of Neuroscience, 29(38), 12004), recognition of familiar versus unfamiliar faces, and even the processing of racial in-group versus out-group faces (De Dreu et al., 2011, Proceedings of the National Academy of Sciences, 108(4), 1262–1266).

Rimmele et al. (2009) found that oxytocin specifically enhanced memory for faces – but not non-social stimuli like houses or landscapes. This selectivity reinforces the idea that oxytocin is not a general cognitive enhancer but a social signal amplifier, selectively boosting the processing of socially relevant information.

De Dreu et al. (2011) introduced a more complex dimension by showing that oxytocin’s pro-social effects can be in-group biased. Participants receiving oxytocin showed enhanced empathy and cooperation toward in-group members but not out-group members – and in some conditions, increased competitive behaviour toward out-group faces. This “parochial altruism” effect reminds us that oxytocin’s social-cognitive effects are shaped by context, identity, and group dynamics.

For a deeper exploration of oxytocin’s emotional effects, see our page on oxytocin and emotion.

Summary of Key Findings

The evidence on oxytocin and facial recognition can be distilled into several well-supported conclusions:

• Enhanced emotion reading: Intranasal oxytocin improves the ability to infer complex mental states from faces, particularly from the eye region (Domes et al., 2007).
• Increased eye gaze: Oxytocin shifts visual attention toward the eyes – the most socially informative part of the face (Guastella et al., 2008).
• Amygdala modulation: Oxytocin reduces amygdala reactivity to threatening faces while potentially increasing sensitivity to caregiving-relevant stimuli (Kirsch et al., 2005; Riem et al., 2011).
• Trust and approach: Oxytocin increases ratings of facial trustworthiness and attractiveness (Theodoridou et al., 2009).
• Autism relevance: Acute oxytocin doses can improve face-based emotion recognition in autism, though long-term therapeutic effects remain unproven (Guastella et al., 2010; Sikich et al., 2021).
• Social memory: Oxytocin selectively enhances memory for faces over non-social stimuli (Rimmele et al., 2009).

Cited Studies

For full references and further reading, visit our references page.

• Andari, E., Duhamel, J.R., Zalla, T., Herbrecht, E., Leboyer, M., & Sirigu, A. (2010). Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proceedings of the National Academy of Sciences, 107(9), 4389–4394.
• De Dreu, C.K., Greer, L.L., Van Kleef, G.A., Shalvi, S., & Handgraaf, M.J. (2011). Oxytocin promotes human ethnocentrism. Proceedings of the National Academy of Sciences, 108(4), 1262–1266.
• Domes, G., Heinrichs, M., Michel, A., Berger, C., & Herpertz, S.C. (2007). Oxytocin improves “mind-reading” in humans. Biological Psychiatry, 61(6), 731–733.
• Gamer, M., Zurowski, B., & Büchel, C. (2010). Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans. Proceedings of the National Academy of Sciences, 107(20), 9400–9405.
• Guastella, A.J., Mitchell, P.B., & Dadds, M.R. (2008). Oxytocin increases gaze to the eye region of human faces. Biological Psychiatry, 63(1), 3–5.
• Guastella, A.J., Einfeld, S.L., Gray, K.M., Rinehart, N.J., Tonge, B.J., Lambert, T.J., & Hickie, I.B. (2010). Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biological Psychiatry, 67(7), 692–694.
• Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., … & Meyer-Lindenberg, A. (2005). Oxytocin modulates neural circuitry for social cognition and fear in humans. Journal of Neuroscience, 25(49), 11489–11493.
• Kosfeld, M., Heinrichs, M., Zak, P.J., Fischbacher, U., & Fehr, E. (2005). Oxytocin increases trust in humans. Nature, 435(7042), 673–676.
• Lischke, A., Berger, C., Prehn, K., Heinrichs, M., Herpertz, S.C., & Domes, G. (2012). Intranasal oxytocin enhances emotion recognition from dynamic facial expressions and leaves eye-gaze unaffected. Psychoneuroendocrinology, 37(4), 475–481.
• Riem, M.M., Bakermans-Kranenburg, M.J., Pieper, S., Tops, M., Boksem, M.A., Vermeiren, R.R., … & Rombouts, S.A. (2011). Oxytocin modulates amygdala, insula, and inferior frontal gyrus responses to infant crying. Biological Psychiatry, 70(3), 277–282.
• Rimmele, U., Hediger, K., Heinrichs, M., & Klaver, P. (2009). Oxytocin makes a face in memory familiar. Journal of Neuroscience, 29(1), 38–42.
• Shamay-Tsoory, S.G. & Abu-Akel, A. (2016). The social salience hypothesis of oxytocin. Biological Psychiatry, 79(3), 194–202.
• Sikich, L., Kolevzon, A., King, B.H., et al. (2021). Intranasal oxytocin in children and adolescents with autism spectrum disorder. New England Journal of Medicine, 385(16), 1462–1473.
• Theodoridou, A., Rowe, A.C., Penton-Voak, I.S., & Rogers, P.J. (2009). Oxytocin and social perception: Oxytocin increases perceived facial trustworthiness and attractiveness. Hormones and Behavior, 56(1), 128–132.

Frequently Asked Questions